Amneal Pharmaceuticals

company

About

Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States.

  • 5001 - 10000

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$854M
Industries
Manufacturing,Medical,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
5001 - 10000
Operating Status
Active

Amneal is much more than just a company. It is a remarkable collection of dynamic and innovative people dedicated to the constant pursuit of excellence.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$854M
Amneal Pharmaceuticals has raised a total of $854M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2017 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2017 Post-IPO Equity $854M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Amneal Pharmaceuticals is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG Post-IPO Equity